Author

Pierre Lacroix

Observed names: P LACROIX, P Lacroix, P. LACROIX, P. Lacroix, PIERRE LACROIX, Pierre LACROIX

Observed institutions: Inserm, Porsolt (France), Institut des Textes et Manuscrits Modernes, Institut National de la Recherche Agronomique, Université Rennes 1, Université de Clermont I, Biotrial (France), Université de Rennes, Université de Reims Champagne-Ardenne

ORCID: 0000-0002-9096-4414

Observed ORCID: 0000-0002-9096-4414

OpenAlex ID: A5085576375

Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk

2003 · Pierre Lacroix, William J Crumb, et al. · European Journal of Pharmacology · 40

S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: I. Interaction with Cloned Human (h)5-HT1A, Dopamine hD2/hD3 and hα2A-Adrenergic Receptors in Relation to Modulation of Cortical Monoamine Release and Activity in Models of Potential Antidepressant Activity

1997 · Mark J. Millan, Adrian Newman-Tancredi, et al. · Journal of Pharmacology and Experimental Therapeutics · 40

The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk

2007 · Niklaus Dürmüller, Philippe Guillaume, et al. · Journal of Pharmacological and Toxicological Methods · 35

QT interval prolongation by noncardiovascular drugs: A proposed assessment strategy

1999 · Bernard Pourrias, Roger D. Porsolt, et al. · Drug Development Research · 31

QT interval prolongation and cardiac risk assessment for novel drugs.

2003 · Sandra Picard, Pierre Lacroix · PubMed · 25

International safety pharmacology guidelines (ICH S7A and S7B): where do we go from here?

2005 · Roger D. Porsolt, Sandra Picard, et al. · Drug Development Research · 21

Basic safety pharmacology: the cardiovascular system.

2000 · P Lacroix, D Provost · PubMed · 21

Sudden death and experimental acute myocardial infarction

1985 · Yvette Trolese-Mongheal, Pierre Duchene-Marullaz, et al. · The American Journal of Cardiology · 20

Diproteverine (BRL 40015): a new type of calcium antagonist with potential antianginal properties

1991 · Pierre Lacroix, Philippe Linee, et al. · European Journal of Pharmacology · 14

Cerebral Metabolic, Hemodynamic and Antihypoxic Properties of l-Eburnamonine

2008 · Ph. Linée, P. Lacroix, et al. · European Neurology · 12

Potential Biological Targets for Anti-Alzheimer Drugs

1993 · H. Allain, S. Belliard, et al. · Dementia and Geriatric Cognitive Disorders · 11

Gastrointestinal Models: Intestinal Transit, Gastric Emptying, and Ulcerogenic Activity in the Rat

2008 · Philippe Guillaume, Daniel Provost, et al. · Current Protocols in Pharmacology · 9

P-2-8 Antidepressant effects of milnacipran in the learned helplessness test in rats

1995 · P Lacroix, N. Rocher, et al. · European Neuropsychopharmacology · 9

Effects of some coronary vasodilator drugs on collateral hemodynamics after chronic myocardial ischemia in the anesthetized dog: appropriate or inappropriate redistribution?

1978 · P Lacroix, P Linee, et al. · Journal of Pharmacology and Experimental Therapeutics · 9

[Effects of co-administration of an antidepressant and an anxiolytic drug in the "learned helplessness" paradigm: importance of hydroxyzine].

1996 · P Martin, N Guillou, et al. · PubMed · 8

Effects of dimethylformamide on in vivo fatigue and metabolism in rat skeletal muscle measured by 31P-NMR

1996 · Nathalie Le Tallec, Pierre Lacroix, et al. · Journal of Pharmacological and Toxicological Methods · 8

Antidepressant effects of tianeptine, of its two enantiomers and its predominant metabolite in the learned helplessness test in rats

1996 · P. Lacroix, N. Rocher, et al. · European Neuropsychopharmacology · 6

Effects of S.12024-2 on memory impairment in aged rats

1993 · P. Lacroix, J.M. Reymann, et al. · European Neuropsychopharmacology · 6

[Cerebral protecting activity of 1-eburnamonine studied on 3 models of acute hypoxic agression. Comparison with vincamine].

1977 · P Linée, G Perrault, et al. · PubMed · 6

Influence of Enalapril Therapy Schedule on the Progression of the Disease in Dilated Cardiomyopathic Syrian Hamsters (Bio TO-2 strain)

2010 · Sonia Goineau, Pierre Lacroix, et al. · Journal of Clinical & Experimental Cardiology · 5

Models of Cardiovascular Disease: Measurement of Antihypertensive Activity in the Conscious Rat (SHR, DOCA‐Salt, and Goldblatt Hypertension Models)

2009 · Philippe Guillaume, Daniel Provost, et al. · Current Protocols in Pharmacology · 5

Safety Pharmacology II-CV, GI, Respiratory and Renal Safety

2007 · Michael Williams, Roger D. Porsolt, et al. · Elsevier eBooks · 5

Cerebral metabolic and hemodynamic activities of l-eburnamonine in the anesthetized dog. A comparison with vincamine.

1979 · P Lacroix, M J Quiniou, et al. · PubMed · 5

Cardiac safety profile of etamicastat, a novel peripheral selective dopamine-β-hydroxylase inhibitor in non-human primates, human young and elderly healthy volunteers and hypertensive patients

2015 · Manuel Vaz-da-Silva, José-Francisco Rocha, et al. · IJC Metabolic & Endocrine · 4

Orthostatic Hypotension Induced by Postural Change in the Rat (Tilt Test)

2008 · Philippe Guillaume, Stéphane Hervé, et al. · Current Protocols in Pharmacology · 3

Works count: 66

Citation count: 380

H-index: 11

I10-index: 11